The Mittal Institute’s recent panel webinar in collaboration with Harvard Business School India Research Center and Harvard Business Publishing, “Science, Business, and Vaccine Development to Combat the Pandemic,” was moderated by Tarun Khanna, Jorge Paulo Lemann Professor at Harvard Business School and Director of the Mittal Institute.
Together, the panelists discussed the geopolitics of how vaccines are developed, the funding and distribution methods that are critical to the effort, and the global alliances that facilitate this in the world today, with the objective to share the mechanics and commerce of vaccine development and the critical role that science and business can play in combating pandemics such as COVID-19.
Professor Khanna was joined by three experts on the subject:
- Gagandeep Kang, Executive Director, Translational Health Science and Technology Institute & Vice Chairperson of The Coalition for Epidemic Preparedness Innovations
- Umang Vohra, Managing Director & Global Chief Executive Officer, Cipla Ltd.
- David E. Bloom, Clarence James Gamble Professor of Economics & Demography, Harvard T.H. Chan School of Public Health